{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T02:02:25Z","timestamp":1784599345456,"version":"3.55.0"},"reference-count":41,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.36372","type":"journal-article","created":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T16:33:36Z","timestamp":1638203616000},"page":"e2136372","source":"Crossref","is-referenced-by-count":7,"title":["Comparison of Cardiovascular Safety for Smoking Cessation Pharmacotherapies in a Population-Based Cohort in Australia"],"prefix":"10.1001","volume":"4","author":[{"given":"Alys","family":"Havard","sequence":"first","affiliation":[{"name":"National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Sydney, New South Wales, Australia"},{"name":"Centre for Big Data Research in Health, University of New South Wales, Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie K. Y.","family":"Choi","sequence":"additional","affiliation":[{"name":"Centre for Big Data Research in Health, University of New South Wales, Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sallie-Anne","family":"Pearson","sequence":"additional","affiliation":[{"name":"Centre for Big Data Research in Health, University of New South Wales, Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara K.","family":"Chow","sequence":"additional","affiliation":[{"name":"Westmead Applied Research Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duong T.","family":"Tran","sequence":"additional","affiliation":[{"name":"Centre for Big Data Research in Health, University of New South Wales, Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian B.","family":"Filion","sequence":"additional","affiliation":[{"name":"Centre for Clinical Epidemiology, Lady Davis Research Institute, Jewish General Hospital, Montreal, Quebec, Canada"},{"name":"Department of Medicine, McGill University, Montreal, Quebec, Canada"},{"name":"Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,11,29]]},"reference":[{"issue":"10082","key":"zoi211025r1","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/S0140-6736(17)30819-X","article-title":"Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015.","volume":"389","author":"GBD 2015 Tobacco Collaborators","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"zoi211025r3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41533-016-0004-8","article-title":"National guidelines for smoking cessation in primary care: a literature review and evidence analysis.","volume":"27","author":"Verbiest","year":"2017","journal-title":"NPJ Prim Care Respir Med"},{"issue":"5","key":"zoi211025r4","article-title":"Pharmacological interventions for smoking cessation: an overview and network meta-analysis.","author":"Cahill","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"zoi211025r5","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.jacc.2012.08.1030","article-title":"Bupropion for smoking cessation in patients hospitalized with acute myocardial infarction: a randomized, placebo-controlled trial.","volume":"61","author":"Eisenberg","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"zoi211025r6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1161\/CIRCULATIONAHA.113.003961","article-title":"Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis.","volume":"129","author":"Mills","year":"2014","journal-title":"Circulation"},{"issue":"2","key":"zoi211025r7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1161\/CIRCULATIONAHA.109.869008","article-title":"Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial.","volume":"121","author":"Rigotti","year":"2010","journal-title":"Circulation"},{"issue":"12","key":"zoi211025r8","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.amjmed.2006.04.024","article-title":"Bupropion for smokers hospitalized with acute cardiovascular disease.","volume":"119","author":"Rigotti","year":"2006","journal-title":"Am J Med"},{"issue":"12","key":"zoi211025r9","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1503\/cmaj.110218","article-title":"Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis.","volume":"183","author":"Singh","year":"2011","journal-title":"CMAJ"},{"issue":"10","key":"zoi211025r10","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/S0195-668X(03)00003-4","article-title":"Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study.","volume":"24","author":"Tonstad","year":"2003","journal-title":"Eur Heart J"},{"issue":"6","key":"zoi211025r11","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1053\/pcad.2003.YPCAD14","article-title":"Safety issues in pharmacotherapy for smoking in patients with cardiovascular disease.","volume":"45","author":"Joseph","year":"2003","journal-title":"Prog Cardiovasc Dis"},{"key":"zoi211025r12","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e2856","article-title":"Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis.","volume":"344","author":"Prochaska","year":"2012","journal-title":"BMJ"},{"issue":"2","key":"zoi211025r13","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002849","article-title":"Varenicline and adverse cardiovascular events: a systematic review and meta-analysis of randomized controlled trials.","volume":"5","author":"Sterling","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"zoi211025r14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jash.2012.11.003","article-title":"Cardiovascular effects of pharmacologic therapies for smoking cessation.","volume":"7","author":"Sobieraj","year":"2013","journal-title":"J Am Soc Hypertens"},{"issue":"5","key":"zoi211025r15","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1001\/jamainternmed.2018.0397","article-title":"Cardiovascular safety of varenicline, bupropion, and nicotine patch in smokers: a randomized clinical trial.","volume":"178","author":"Benowitz","year":"2018","journal-title":"JAMA Intern Med"},{"key":"zoi211025r16","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e7176","article-title":"Use of varenicline for smoking cessation and risk of serious cardiovascular events: nationwide cohort study.","volume":"345","author":"Svanstr\u00f6m","year":"2012","journal-title":"BMJ"},{"issue":"10","key":"zoi211025r17","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S2213-2600(15)00320-3","article-title":"Cardiovascular and neuropsychiatric risks of varenicline: a retrospective cohort study.","volume":"3","author":"Kotz","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"8","key":"zoi211025r18","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1111\/add.v115.8","article-title":"Cardiovascular and neuropsychiatric safety of smoking cessation pharmacotherapies in non-depressed adults: a retrospective cohort study.","volume":"115","author":"Carney","year":"2020","journal-title":"Addiction"},{"issue":"2","key":"zoi211025r19","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1093\/ntr\/ntaa100","article-title":"Comparative safety of smoking cessation pharmacotherapies during a government sponsored reimbursement program.","volume":"23","author":"Carney","year":"2021","journal-title":"Nicotine Tob Res"},{"issue":"11","key":"zoi211025r20","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/pds.v23.11","article-title":"Cardiovascular and mortality risks in older Medicare patients treated with varenicline or bupropion for smoking cessation: an observational cohort study.","volume":"23","author":"Graham","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9","key":"zoi211025r21","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1001\/jamainternmed.2013.3004","article-title":"Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration\u2019s Mini-Sentinel program.","volume":"173","author":"Toh","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"11","key":"zoi211025r24","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1097\/01.mlr.0000228018.48783.34","article-title":"Quality of diagnosis and procedure coding in ICD-10 administrative data.","volume":"44","author":"Henderson","year":"2006","journal-title":"Med Care"},{"issue":"28","key":"zoi211025r28","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1002\/sim.v34.28","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies.","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"issue":"4","key":"zoi211025r29","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/EDE.0b013e3181a663cc","article-title":"High-dimensional propensity score adjustment in studies of treatment effects using health care claims data.","volume":"20","author":"Schneeweiss","year":"2009","journal-title":"Epidemiology"},{"issue":"25","key":"zoi211025r30","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples.","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"issue":"6","key":"zoi211025r31","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/aje\/kwn164","article-title":"Constructing inverse probability weights for marginal structural models.","volume":"168","author":"Cole","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"7","key":"zoi211025r33","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/sim.v33.7","article-title":"The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments.","volume":"33","author":"Austin","year":"2014","journal-title":"Stat Med"},{"issue":"6","key":"zoi211025r34","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/aje\/kwk052","article-title":"Relaxing the rule of ten events per variable in logistic and Cox regression.","volume":"165","author":"Vittinghoff","year":"2007","journal-title":"Am J Epidemiol"},{"key":"zoi211025r35","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/biomet\/80.3.557","article-title":"Checking the Cox model with cumulative sums of martingale-based residuals.","volume":"80","author":"Lin","year":"1993","journal-title":"Biometrika"},{"issue":"9536","key":"zoi211025r36","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S0140-6736(06)69249-0","article-title":"Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study.","volume":"368","author":"Teo","year":"2006","journal-title":"Lancet"},{"issue":"10037","key":"zoi211025r37","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1016\/S0140-6736(16)30272-0","article-title":"Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.","volume":"387","author":"Anthenelli","year":"2016","journal-title":"Lancet"},{"key":"zoi211025r38","doi-asserted-by":"publisher","first-page":"b3805","DOI":"10.1136\/bmj.b3805","article-title":"Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database.","volume":"339","author":"Gunnell","year":"2009","journal-title":"BMJ"},{"key":"zoi211025r39","doi-asserted-by":"publisher","first-page":"f5704","DOI":"10.1136\/bmj.f5704","article-title":"Smoking cessation treatment and risk of depression, suicide, and self harm in the Clinical Practice Research Datalink: prospective cohort study.","volume":"347","author":"Thomas","year":"2013","journal-title":"BMJ"},{"issue":"11","key":"zoi211025r41","doi-asserted-by":"publisher","first-page":"582","DOI":"10.5694\/mja2.2015.202.issue-11","article-title":"Cross border hospital use: analysis using data linkage across four Australian states.","volume":"202","author":"Spilsbury","year":"2015","journal-title":"Med J Aust"},{"key":"zoi211025r2","volume-title":"Smoking Cessation: A Report of the Surgeon General.","author":"US Dept of Health and Human Services","year":"2020"},{"key":"zoi211025r23","volume-title":"The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM)","author":"National Centre for Classification in Health","year":"2008","edition":"5th ed"},{"key":"zoi211025r32","doi-asserted-by":"crossref","DOI":"10.1201\/9780429246593","volume-title":"An Introduction to the Bootstrap","author":"Efron","year":"1994"},{"key":"zoi211025r22","unstructured":"Australian Government Department of Health. Pharmaceutical benefits: fees, patient contributions and safety net thresholds. Updated July 1, 2021. Accessed September 2, 2021. https:\/\/www.pbs.gov.au\/info\/healthpro\/explanatory-notes\/front\/fee"},{"key":"zoi211025r25","unstructured":"Australian Government Department of Health, Therapeutic Goods Administration. Australian Register of Therapeutic Goods. Updated October 14, 2021. Accessed March 8, 2021. https:\/\/www.ebs.tga.gov.au\/"},{"key":"zoi211025r26","unstructured":"Australian Bureau of Statistics. 2033.0.55.001\u2013Census of Population and Housing: Socio-Economic Indexes for Areas (SEIFA), Australia, 2016. Updated March 27, 2018. Accessed May 14, 2020. https:\/\/www.abs.gov.au\/ausstats\/abs@.nsf\/mf\/2033.0.55.001"},{"key":"zoi211025r27","unstructured":"Australian Bureau of Statistics. Australian Statistical Geography Standard (ASGS) Remoteness Structure. 2016. Accessed November 6, 2019. https:\/\/www.abs.gov.au\/websitedbs\/D3310114.nsf\/home\/remoteness+structure"},{"key":"zoi211025r40","unstructured":"US Food and Drug Administration. FDA safety communication: FDA revises description of mental health side effects of the stop-smoking medicines Chantix (varenicline) and Zyban (bupropion) to reflect clinical trial findings. December 16, 2016. Accessed September 11, 2020. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-revises-description-mental-health-side-effects-stop-smoking"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2786678\/havard_2021_oi_211025_1637393785.27473.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T16:33:46Z","timestamp":1638203626000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2786678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,29]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.36372","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,29]]}}}